Loading…

Trends in colorectal cancer screening in the United States, 2012 to 2020

Objectives Despite recommendations to increase the uptake of colorectal cancer (CRC) screening, trends in CRC screening vary with sociodemographic status. We aimed to evaluate trends in CRC screening in the US population and subpopulations. Methods A total of 1,082,924 participants aged 50 to 75 fro...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical screening 2023-09, Vol.30 (3), p.125-133
Main Authors: He, Yue, Xu, Tong, Fang, Jiaxin, Tong, Li, Gao, Wenhui, Zhang, Yuan, Wang, Yanfang, Xu, Yan, Shi, Shunyao, Liu, Siyu, Jin, Lina
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563
cites cdi_FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563
container_end_page 133
container_issue 3
container_start_page 125
container_title Journal of medical screening
container_volume 30
creator He, Yue
Xu, Tong
Fang, Jiaxin
Tong, Li
Gao, Wenhui
Zhang, Yuan
Wang, Yanfang
Xu, Yan
Shi, Shunyao
Liu, Siyu
Jin, Lina
description Objectives Despite recommendations to increase the uptake of colorectal cancer (CRC) screening, trends in CRC screening vary with sociodemographic status. We aimed to evaluate trends in CRC screening in the US population and subpopulations. Methods A total of 1,082,924 participants aged 50 to 75 from five cycles (2012, 2014, 2016, 2018, and 2020) of the Behavioral Risk Factor Surveillance System were involved. Multivariable logistic regression models were performed to evaluate linear trends in CRC screening utilization from 2012 to 2018. Rao-Scott chi-square tests were used to assess the differences in CRC screening utilization between 2018 and 2020. Results The estimated percentage reporting up-to-date with CRC screening increased significantly (P for trend
doi_str_mv 10.1177/09691413231174163
format article
fullrecord <record><control><sourceid>sage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1177_09691413231174163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_09691413231174163</sage_id><sourcerecordid>10.1177_09691413231174163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563</originalsourceid><addsrcrecordid>eNp9kM1KAzEUhYMoOFYfwF0ewKlJbv5mKUWtUHBhux4y6U2dMmYkiQvf3hnqTnB1OJzzXS6HkFvOlpwbc88a3XDJQcBkJddwRioujaqVaeCcVHNez4VLcpXzkTE2FW1F1tuEcZ9pH6kfhzGhL26g3kWPiWafEGMfD3Nc3pHuYl9wT9-KK5jvqGBc0DJOKtg1uQhuyHjzqwuye3rcrtb15vX5ZfWwqT1IVmpoOHQMpEKhvAaNQRulgnIudF55pYMGK5mAjqMwwoagbeis1dJiZ5WGBeGnuz6NOScM7WfqP1z6bjlr5ynaP1NMzPLEZHfA9jh-pTi9-A_wA9GYW1U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Trends in colorectal cancer screening in the United States, 2012 to 2020</title><source>SAGE</source><creator>He, Yue ; Xu, Tong ; Fang, Jiaxin ; Tong, Li ; Gao, Wenhui ; Zhang, Yuan ; Wang, Yanfang ; Xu, Yan ; Shi, Shunyao ; Liu, Siyu ; Jin, Lina</creator><creatorcontrib>He, Yue ; Xu, Tong ; Fang, Jiaxin ; Tong, Li ; Gao, Wenhui ; Zhang, Yuan ; Wang, Yanfang ; Xu, Yan ; Shi, Shunyao ; Liu, Siyu ; Jin, Lina</creatorcontrib><description>Objectives Despite recommendations to increase the uptake of colorectal cancer (CRC) screening, trends in CRC screening vary with sociodemographic status. We aimed to evaluate trends in CRC screening in the US population and subpopulations. Methods A total of 1,082,924 participants aged 50 to 75 from five cycles (2012, 2014, 2016, 2018, and 2020) of the Behavioral Risk Factor Surveillance System were involved. Multivariable logistic regression models were performed to evaluate linear trends in CRC screening utilization from 2012 to 2018. Rao-Scott chi-square tests were used to assess the differences in CRC screening utilization between 2018 and 2020. Results The estimated percentage reporting up-to-date with CRC screening increased significantly (P for trend &lt;0.001), from 62.8% (95% CI, 62.4%−63.2%) in 2012 to 66.7% (95% CI, 66.3%−67.2%) in 2018 and 70.4% (95% CI, 69.8%−71.0%) in 2020, in accordance with 2008 US Preventive Services Task Force recommendations. Trends followed similar patterns in most subgroups, although with different magnitudes in several subgroups, primarily those underweight showed a stable percentage over time (P for trend  =  0.170). In 2020, 72.4% of participants reported they were up to date with CRC screening, including the utilization of stool DNA tests and virtual colonoscopy. Colonoscopy was the most commonly used test in 2020 (64.5%), followed by FOBT (12.6%), stool DNA test (5.8%), sigmoidoscopy (3.8%), and virtual colonoscopy (2.7%). Conclusions In this nationally representative survey of the US population from 2012 through 2020, the percentage reporting up to date with CRC screening has increased, but not equally among all subgroups.</description><identifier>ISSN: 0969-1413</identifier><identifier>EISSN: 1475-5793</identifier><identifier>DOI: 10.1177/09691413231174163</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><ispartof>Journal of medical screening, 2023-09, Vol.30 (3), p.125-133</ispartof><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563</citedby><cites>FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563</cites><orcidid>0000-0002-8961-2809</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79236</link.rule.ids></links><search><creatorcontrib>He, Yue</creatorcontrib><creatorcontrib>Xu, Tong</creatorcontrib><creatorcontrib>Fang, Jiaxin</creatorcontrib><creatorcontrib>Tong, Li</creatorcontrib><creatorcontrib>Gao, Wenhui</creatorcontrib><creatorcontrib>Zhang, Yuan</creatorcontrib><creatorcontrib>Wang, Yanfang</creatorcontrib><creatorcontrib>Xu, Yan</creatorcontrib><creatorcontrib>Shi, Shunyao</creatorcontrib><creatorcontrib>Liu, Siyu</creatorcontrib><creatorcontrib>Jin, Lina</creatorcontrib><title>Trends in colorectal cancer screening in the United States, 2012 to 2020</title><title>Journal of medical screening</title><addtitle>Journal of Medical Screening</addtitle><description>Objectives Despite recommendations to increase the uptake of colorectal cancer (CRC) screening, trends in CRC screening vary with sociodemographic status. We aimed to evaluate trends in CRC screening in the US population and subpopulations. Methods A total of 1,082,924 participants aged 50 to 75 from five cycles (2012, 2014, 2016, 2018, and 2020) of the Behavioral Risk Factor Surveillance System were involved. Multivariable logistic regression models were performed to evaluate linear trends in CRC screening utilization from 2012 to 2018. Rao-Scott chi-square tests were used to assess the differences in CRC screening utilization between 2018 and 2020. Results The estimated percentage reporting up-to-date with CRC screening increased significantly (P for trend &lt;0.001), from 62.8% (95% CI, 62.4%−63.2%) in 2012 to 66.7% (95% CI, 66.3%−67.2%) in 2018 and 70.4% (95% CI, 69.8%−71.0%) in 2020, in accordance with 2008 US Preventive Services Task Force recommendations. Trends followed similar patterns in most subgroups, although with different magnitudes in several subgroups, primarily those underweight showed a stable percentage over time (P for trend  =  0.170). In 2020, 72.4% of participants reported they were up to date with CRC screening, including the utilization of stool DNA tests and virtual colonoscopy. Colonoscopy was the most commonly used test in 2020 (64.5%), followed by FOBT (12.6%), stool DNA test (5.8%), sigmoidoscopy (3.8%), and virtual colonoscopy (2.7%). Conclusions In this nationally representative survey of the US population from 2012 through 2020, the percentage reporting up to date with CRC screening has increased, but not equally among all subgroups.</description><issn>0969-1413</issn><issn>1475-5793</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kM1KAzEUhYMoOFYfwF0ewKlJbv5mKUWtUHBhux4y6U2dMmYkiQvf3hnqTnB1OJzzXS6HkFvOlpwbc88a3XDJQcBkJddwRioujaqVaeCcVHNez4VLcpXzkTE2FW1F1tuEcZ9pH6kfhzGhL26g3kWPiWafEGMfD3Nc3pHuYl9wT9-KK5jvqGBc0DJOKtg1uQhuyHjzqwuye3rcrtb15vX5ZfWwqT1IVmpoOHQMpEKhvAaNQRulgnIudF55pYMGK5mAjqMwwoagbeis1dJiZ5WGBeGnuz6NOScM7WfqP1z6bjlr5ynaP1NMzPLEZHfA9jh-pTi9-A_wA9GYW1U</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>He, Yue</creator><creator>Xu, Tong</creator><creator>Fang, Jiaxin</creator><creator>Tong, Li</creator><creator>Gao, Wenhui</creator><creator>Zhang, Yuan</creator><creator>Wang, Yanfang</creator><creator>Xu, Yan</creator><creator>Shi, Shunyao</creator><creator>Liu, Siyu</creator><creator>Jin, Lina</creator><general>SAGE Publications</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-8961-2809</orcidid></search><sort><creationdate>202309</creationdate><title>Trends in colorectal cancer screening in the United States, 2012 to 2020</title><author>He, Yue ; Xu, Tong ; Fang, Jiaxin ; Tong, Li ; Gao, Wenhui ; Zhang, Yuan ; Wang, Yanfang ; Xu, Yan ; Shi, Shunyao ; Liu, Siyu ; Jin, Lina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Yue</creatorcontrib><creatorcontrib>Xu, Tong</creatorcontrib><creatorcontrib>Fang, Jiaxin</creatorcontrib><creatorcontrib>Tong, Li</creatorcontrib><creatorcontrib>Gao, Wenhui</creatorcontrib><creatorcontrib>Zhang, Yuan</creatorcontrib><creatorcontrib>Wang, Yanfang</creatorcontrib><creatorcontrib>Xu, Yan</creatorcontrib><creatorcontrib>Shi, Shunyao</creatorcontrib><creatorcontrib>Liu, Siyu</creatorcontrib><creatorcontrib>Jin, Lina</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of medical screening</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Yue</au><au>Xu, Tong</au><au>Fang, Jiaxin</au><au>Tong, Li</au><au>Gao, Wenhui</au><au>Zhang, Yuan</au><au>Wang, Yanfang</au><au>Xu, Yan</au><au>Shi, Shunyao</au><au>Liu, Siyu</au><au>Jin, Lina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in colorectal cancer screening in the United States, 2012 to 2020</atitle><jtitle>Journal of medical screening</jtitle><addtitle>Journal of Medical Screening</addtitle><date>2023-09</date><risdate>2023</risdate><volume>30</volume><issue>3</issue><spage>125</spage><epage>133</epage><pages>125-133</pages><issn>0969-1413</issn><eissn>1475-5793</eissn><abstract>Objectives Despite recommendations to increase the uptake of colorectal cancer (CRC) screening, trends in CRC screening vary with sociodemographic status. We aimed to evaluate trends in CRC screening in the US population and subpopulations. Methods A total of 1,082,924 participants aged 50 to 75 from five cycles (2012, 2014, 2016, 2018, and 2020) of the Behavioral Risk Factor Surveillance System were involved. Multivariable logistic regression models were performed to evaluate linear trends in CRC screening utilization from 2012 to 2018. Rao-Scott chi-square tests were used to assess the differences in CRC screening utilization between 2018 and 2020. Results The estimated percentage reporting up-to-date with CRC screening increased significantly (P for trend &lt;0.001), from 62.8% (95% CI, 62.4%−63.2%) in 2012 to 66.7% (95% CI, 66.3%−67.2%) in 2018 and 70.4% (95% CI, 69.8%−71.0%) in 2020, in accordance with 2008 US Preventive Services Task Force recommendations. Trends followed similar patterns in most subgroups, although with different magnitudes in several subgroups, primarily those underweight showed a stable percentage over time (P for trend  =  0.170). In 2020, 72.4% of participants reported they were up to date with CRC screening, including the utilization of stool DNA tests and virtual colonoscopy. Colonoscopy was the most commonly used test in 2020 (64.5%), followed by FOBT (12.6%), stool DNA test (5.8%), sigmoidoscopy (3.8%), and virtual colonoscopy (2.7%). Conclusions In this nationally representative survey of the US population from 2012 through 2020, the percentage reporting up to date with CRC screening has increased, but not equally among all subgroups.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1177/09691413231174163</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-8961-2809</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0969-1413
ispartof Journal of medical screening, 2023-09, Vol.30 (3), p.125-133
issn 0969-1413
1475-5793
language eng
recordid cdi_crossref_primary_10_1177_09691413231174163
source SAGE
title Trends in colorectal cancer screening in the United States, 2012 to 2020
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A24%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20colorectal%20cancer%20screening%20in%20the%20United%20States,%202012%20to%202020&rft.jtitle=Journal%20of%20medical%20screening&rft.au=He,%20Yue&rft.date=2023-09&rft.volume=30&rft.issue=3&rft.spage=125&rft.epage=133&rft.pages=125-133&rft.issn=0969-1413&rft.eissn=1475-5793&rft_id=info:doi/10.1177/09691413231174163&rft_dat=%3Csage_cross%3E10.1177_09691413231174163%3C/sage_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c340t-3913b0345e25c636ef6755f5aafbc5c56f6384023b1e2728ff68fb88648eb8563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_sage_id=10.1177_09691413231174163&rfr_iscdi=true